FRED HUTCHINSON CANCER CENTER
Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia
- Conditions
- First Posted Date
- 2005-07-13
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT00119340
- Locations
- 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸Veterans Affairs Medical Center - Seattle, Seattle, Washington, United States
Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes
- Conditions
- Interventions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT00118287
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
- Conditions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2011-09-01
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 41
- Registration Number
- NCT00118339
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease
- Conditions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2010-05-14
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00118326
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
- Conditions
- Acute Undifferentiated LeukemiaAngioimmunoblastic T-cell LymphomaChildhood Acute Lymphoblastic Leukemia in RemissionHepatosplenic T-cell LymphomaMast Cell LeukemiaRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid LeukemiaRecurrent Adult Burkitt LymphomaAdult Acute Lymphoblastic Leukemia in RemissionAtypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- Interventions
- Biological: alemtuzumabRadiation: total-body irradiationDrug: fludarabine phosphateDrug: cyclosporineDrug: mycophenolate mofetilProcedure: allogeneic hematopoietic stem cell transplantationProcedure: peripheral blood stem cell transplantationBiological: graft versus host disease prophylaxis/therapyOther: laboratory biomarker analysis
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT00118352
- Locations
- 🇮🇹
University of Torino, Torino, Italy
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Hutchinson Smoking Prevention Project
- First Posted Date
- 2005-06-27
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 8388
- Registration Number
- NCT00115869
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Hutchinson Study of High School Smoking
- First Posted Date
- 2005-06-27
- Last Posted Date
- 2016-05-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 2151
- Registration Number
- NCT00115882
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
- Conditions
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00112567
- Locations
- 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
- Conditions
- Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)AIDS-related Immunoblastic Large Cell LymphomaChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Immunoblastic Large Cell LymphomaChildhood Myelodysplastic SyndromesChildhood Nasal Type Extranodal NK/T-cell LymphomaChronic Neutrophilic Leukemia
- Interventions
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00112593
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma
- Conditions
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Adult Lymphoblastic LymphomaSplenic Marginal Zone LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Mantle Cell LymphomaNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma
- Interventions
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 38
- Registration Number
- NCT00110071
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States